Mosaic Family Wealth Partners LLC Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Mosaic Family Wealth Partners LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 17.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,814 shares of the healthcare conglomerate’s stock after selling 377 shares during the period. Mosaic Family Wealth Partners LLC’s holdings in UnitedHealth Group were worth $897,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. True Wealth Design LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $31,000. Delos Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the period. Red Tortoise LLC raised its stake in shares of UnitedHealth Group by 45.1% during the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock worth $36,000 after buying an additional 23 shares during the period. Transcendent Capital Group LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $40,000. Finally, Ruedi Wealth Management Inc. raised its stake in shares of UnitedHealth Group by 58.3% during the 1st quarter. Ruedi Wealth Management Inc. now owns 76 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 28 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on UNH shares. Wells Fargo & Company upped their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, July 23rd. Truist Financial increased their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. TD Cowen increased their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, UBS Group increased their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research note on Thursday, July 18th. One research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $614.17.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Up 3.0 %

UnitedHealth Group stock traded up $17.06 during midday trading on Friday, reaching $589.83. 5,094,041 shares of the stock traded hands, compared to its average volume of 4,453,607. The company has a 50-day simple moving average of $514.72 and a two-hundred day simple moving average of $503.15. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $591.54. The firm has a market cap of $542.87 billion, a PE ratio of 36.05, a price-to-earnings-growth ratio of 1.59 and a beta of 0.59. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same period last year, the business posted $6.14 EPS. UnitedHealth Group’s revenue for the quarter was up 6.4% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.